RxDoctor Payments Data

Rebecca Rodriguez, MD

Family Medicine · St. Louis, MONPI 1730491721

Payments from drug & device makers

$2,269in general payments, 2019–2025

Across 128 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$602
  • Supernus Pharmaceuticals, Inc.$218
  • Pfizer$191
  • Amgen$153
  • Lilly USA, LLC$124
  • Novo Nordisk$104
  • plus $877 from 25 others

What the payments were for

  • Food & beverage$2,269100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,269 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$49,275
Medicare patients
144
Services billed
477

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide97$115,975
OzempicSemaglutide45$84,584
EliquisApixaban73$55,649
ZenpepLipase/Protease/Amylase16$48,162
XareltoRivaroxaban28$28,842
LinzessLinaclotide37$22,386
JardianceEmpagliflozin23$20,399
Praluent PenAlirocumab15$9,688
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$7,736
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,380
BelsomraSuvorexant12$6,989
Advair HfaFluticasone Propion/Salmeterol11$3,791
Scopolamine15$3,745
Pregabalin17$3,508
Levothyroxine Sodium347$2,933

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$124$115,97597 claims
Novo NordiskOzempic$104$84,58445 claims
PfizerEliquis$191$55,64973 claims
Aimmune Therapeutics, Inc.Zenpep$101$48,16216 claims
AbbVieLinzess, Synthroid$602$23,77550 claims
Boehringer IngelheimJardiance$17$20,39923 claims
AstraZenecaBreztri Aerosphere$36$7,38011 claims
MerckBelsomra$12$6,98912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in St. Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →